Delivery Order SPE2DB20D1004-SPE2DB24FNCQA

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,679.61, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mupirocin 2% Cream, a pharmaceutical product, to support military treatment facilities and other government healthcare programs. This award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award for $1,119.60 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Mupirocin 2% Cream 15GM. The contract is a delivery order (SPE2DB22D1103|SPE2DB25FTBK0) with a firm fixed price pricing type and an ultimate completion date of November 6, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award is for the delivery of Mupirocin 2% cream, a topical antibiotic medication, to the Defense Logistics Agency (DLA). The $1,096.68 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 29, 2023 with a completion date of August 30, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a $2,964.70 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Mupirocin 2% cream. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,404.12 firm fixed-price contract is for the supply of Mupirocin 2% Ointment 22g to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Mupirocin 2% Cream 15gm, a pharmaceutical product, with a ceiling value of $2,181.41 and a completion date of April 19, 2023. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,448.95 firm fixed-price delivery order is for the supply of MUPIROCIN 2% OINTMENT 22GM, with a performance period ending on January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,262.88 firm fixed-price delivery order is for the supply of 4563691739 - MUPIROCIN 2% CREAM 15GM, with a completion date of February 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mupirocin 2% Cream 15GM. The contract, valued at $4,131.32, is a delivery order awarded on September 8, 2021, with a completion date of September 9, 2021. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc.,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,426.10 firm fixed-price delivery order is for the supply of MUPIROCIN 2% OINTMENT 22GM, with a completion date of December 28, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FNCQA
    Delivery Order

This federal contract award, valued at $1,912.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Mupirocin 2% Cream, 15g, with a completion date of September 19, 2024. The contract is a firm fixed-price arrangement and was not set aside for any specific business category. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:50 AM